GAA
NTLA icon

Green Alpha Advisors’s Intellia Therapeutics NTLA Stock Holding History

Green Alpha Advisors’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-13,886
Closed -$235K – 115
2026
Q2 		$235K Sell
13,886
-281
-2% -$3.93K 0.16% 95
2026
Q1 		$182K Sell
14,167
-2,526
-15% -$32.2K 0.18% 96
2025
Q4 		$150K Buy
+16,693
New +$230K 0.14% 108
2025
Q3 		– Sell
-11,007
Closed -$103K – 106
2025
Q2 		$103K Sell
11,007
-1,461
-12% -$12K 0.1% 101
2025
Q1 		$88.6K Buy
12,468
+669
+6% +$6.76K 0.09% 104
2024
Q4 		$138K Buy
+11,799
New +$184K 0.11% 139
2024
Q2 		– Sell
-7,964
Closed -$219K – 141
2024
Q1 		$219K Sell
7,964
-2,139
-21% -$59.4K 0.16% 129
2023
Q4 		$308K Sell
10,103
-4,674
-32% -$134K 0.22% 131
2023
Q3 		$467K Sell
14,777
-314
-2% -$12.2K 0.36% 94
2023
Q2 		$615K Buy
15,091
+1,187
+9% +$48.1K 0.4% 96
2023
Q1 		$518K Sell
13,904
-1,467
-10% -$57.5K 0.36% 103
2022
Q4 		$536K Buy
15,371
+813
+6% +$38.7K 0.45% 89
2022
Q3 		$815K Sell
14,558
-67,941
-82% -$4.21M 0.69% 60
2022
Q2 		$4.27M Buy
82,499
+71,748
+667% +$3.64M 0.98% 33
2022
Q1 		$781K Buy
10,751
+1,617
+18% +$137K 0.53% 82
2021
Q4 		$1.08M Buy
9,134
+248
+3% +$31.1K 0.73% 61
2021
Q3 		$1.19M Sell
8,886
-370
-4% -$56K 0.82% 47
2021
Q2 		$1.5M Sell
9,256
-738
-7% -$57.5K 1.02% 34
2021
Q1 		$802K Buy
9,994
+5,255
+111% +$353K 0.79% 53
2020
Q4 		$258K Buy
+4,739
New +$172K 0.31% 90

Other funds holding NTLA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $416M AUM 11.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
LAM
Lewis Asset Management Lafayette, California $294M AUM 25.62% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Green Alpha Advisors's NTLA Position: Q3 2026 in Review

Green Alpha Advisors sold out of Intellia Therapeutics (NTLA) in Q3 2026, closing a stake of 13,886 shares — an estimated $235K sold.

Green Alpha Advisors first reported a position in NTLA in Q4 2020 and held it in 20 quarters. The position peaked at $4.27M in Q2 2022. 14 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.

  • Green Alpha Advisors reported no remaining Intellia Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Green Alpha Advisors sold 13,886 Intellia Therapeutics shares in Q3 2026, an estimated $235K.
  • Green Alpha Advisors first reported a position in Intellia Therapeutics in Q4 2020 and held it in 20 quarters.
  • Green Alpha Advisors's Intellia Therapeutics position peaked at $4.27M in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.

Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.